The End Gas Station Heroin Act adds two specific kratom compounds, 7-hydroxymitragynine and mitragynine pseudoindoxyl, to the federal list of Schedule I controlled substances. However, it includes an exemption for these compounds when they occur naturally in finished kratom products that meet strict concentration limits, while explicitly excluding synthetically produced or chemically concentrated versions from this protection. The bill also creates a new enforcement mechanism that treats any emerging synthetic opioid with greater potency than morphine as a Schedule I controlled substance if it is manufactured or distributed for commercial sale. This provision targets the production and distribution of these substances but explicitly prohibits criminal or civil penalties for simple possession or personal use by consumers.
This bill, known as the STOP Nitazenes Act, directs the federal government to permanently classify nitazenes and related synthetic opioids as Schedule I controlled substances, placing them in the same legal category as heroin and fentanyl. The legislation specifically targets a broad range of chemical compounds, including etonitazene and other variants, by defining them as 2-benzylbenzimidazole opioids and requiring the Attorney General to publish a list of qualifying substances. Under the bill, any nitazene substance temporarily scheduled under emergency provisions would be made permanently scheduled upon enactment, ensuring long-term federal control. The law also mandates that the Attorney General issue implementing rules within one year, allowing for immediate interim enforcement while providing opportunities for public comment before final regulations are established.
This bill prohibits federal funding for any state, local, tribal, or private entity operating an injection center that violates the Controlled Substances Act's Crack House Statute (21 U.S.C. 856), which bans drug use in buildings. It directly affects organizations running facilities where illegal drug use occurs, cutting off all federal grants or programs from such entities. The law does not create new drug offenses but withholds existing federal funds from facilities operating in violation of current law. It applies broadly to all federal funding streams, not just specific programs.
This bill redirects federal funding toward mandatory treatment facilities for unhoused individuals with serious mental illness or addiction, while tying grant money to local enforcement of public drug use bans, camping restrictions, and sex offender registration. It prohibits federal support for "harm reduction" programs and safe consumption sites, requires states to prioritize treatment over "housing first" approaches, and mandates data sharing between health programs and law enforcement. The bill defines "unhoused individuals" as those posing public risks or unable to care for themselves for 3+ months. It applies to federal grant programs for homelessness services, mental health treatment, and housing assistance.
HR 5629 would prevent the Department of Health and Human Services' final rule on opioid treatment medications from taking effect, except for changes to accreditation standards for opioid treatment programs. The rule, published in February 2024, aimed to expand access to certain medications for opioid use disorder by modifying treatment protocols. This bill would maintain current regulations for medication-assisted treatment by blocking the rule's implementation, while leaving accreditation requirements unchanged. As a result, existing treatment guidelines would remain in place, but program accreditation standards would still be updated per the rule's exception.
The Jobs and Opportunities for Medicaid Act would require most Medicaid recipients aged 18 to 65 to work or volunteer at least 20 hours per week (averaged monthly) to maintain health coverage, starting January 1, 2026. Exemptions include individuals who are pregnant, primary caregivers for children under 6, medically unable to work, or enrolled in substance abuse treatment programs. States would need to verify each month whether recipients meet this work requirement to continue receiving Medicaid benefits.
The MOSSA Act (HR 4878) directs federal agencies to prioritize funding for local governments enforcing laws against public drug use, camping, and loitering, while requiring homelessness programs to link participants with mental health/substance use treatment as a condition of aid. It mandates that federal grant programs for homelessness services end support for "housing first" approaches and "harm reduction" initiatives, instead requiring evidence-based treatment programs and stricter accountability for service providers. The bill also directs agencies to address sex offenders in homeless programs by restricting their housing with children and to review funding recipients operating drug injection sites for legal violations. These provisions collectively shift federal funding toward enforcement-focused and treatment-oriented homelessness strategies, affecting state/local governments, homeless service providers, and individuals accessing federal housing assistance.
